1 December, 2016
This issue of Respiratory Research Review covers the topics of bronchiectasis and CF (cystic fibrosis).
Byrnes, C.
6 November, 2015
Presentation to Respiratory Conference New Zealand November 2015.
Telfar Barnard, L., Baker, M., Pierse, N., & Zhang, J.
4 April, 2015
This report covers six respiratory disease indicators: asthma, bronchiectasis, childhood bronchiolitis and pneumonia, chronic obstructive pulmonary disease (COPD), and total respiratory disease.
22 November, 2013
This issue focuses on-CF bronchiectasis.
Martinez-Garcia, M., Carrillo, D., Soler-Cataluna, J., Donat-Sanz, Y., Serra, P., Lerma, M., et al.
7 February, 2013
Objectives: To assess the prognostic value of bronchiectasis in patients with moderate-to-severe COPD.
Trenholme, A. et al.
19 September, 2012
The aim of this study was to determine and to describe the presence of respiratory morbidity in young children 1 year after being hospitalized with a severe LRI.
Haidopoulou, K., Calder, A., Jones, A., Jaffe, A., & Sonnappa, S.
9 June, 2009
Primary immunodeficiency is a common cause of bronchiectasis in children. The term bronchiectasis suggests an irreversible process; however, disease progression following treatment is controversial. The aim of this study was to evaluate the progression of bronchiectasis in children with primary immunodeficiency after institution of treatment. The authors concluded that bronchiectasis secondary to primary immunodeficiency in childhood is not always a progressive condition, suggesting a potential to slow or prevent disease progression with appropriate treatment.
Eastham, K., Fall, A., Mitchell, L., & Spencer, D.
26 November, 2003
This study undertook a clinical and radiological review of 93 children with non-CF bronchiectasis. The authors concluded that while bronchiectasis is currently defined as a condition which is both permanent and progressive, this term is not necessarily appropriate for all paediatric patients.
Gaillard, E., Carty, H., & Smyth, R.
9 September, 2003
Bronchiectasis is generally considered irreversible in the adult population, largely based on studies employing bronchography in cases with a significant clinical history. It is assumed that the same is true for children. The objective of this study was to evaluate changes in appearance of bronchial dilatation, unrelated to cystic fibrosis in children, as assessed by sequential high-resolution computer tomography (HRCT) of the lungs. The authors concluded that a radiological diagnosis of bronchiectasis should be considered with caution in children as diagnostic criteria derived from studies in adults have not been validated in children and the condition is generally considered irreversible.
